May 12, 2025, 17:16

NHMRC: Targeted Call for Research: Anal Cancer 2025

This Targeted Call for Research: Anal Cancer 2025 supports research focused on improving awareness, prevention, diagnosis, and treatment of anal cancer. It encourages the development of screening methods, prevention strategies, testing technologies, and health promotion efforts, particularly for high-risk populations such as people living with HIV, MSM, women with HPV, and immunocompromised individuals.

Eligibility Criteria:

Open to eligible researchers and institutions in accordance with GrantConnect requirements. Applicants must coordinate with their administering institution for compliance.

Funding Details:

Duration: 5 years
Amount: Up to AUD 5,000,000 total
Administered through: GrantConnect

Deadline:

Applications open: 05 March 2025
Applications close: 14 May 2025
Peer review period: July – August 2025

Further Information:

Visit GrantConnect for full guidelines and application portal.

Anal Cancer Australia cancer research cancer Cancer Prevention cancer screening cancer stigma cancer treatment Health Promotion high-risk populations HPV immunisation research OncoDaily Oncology public health targeted call for research

FDA Grants Accelerated Approval for Telisotuzumab Vedotin (EMRELIS™) in c-MET–Overexpressing Advanced Non-Small Cell Lung Cancer

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research

In Memory of Bob Marley: His Battle with Melanoma and the Importance of Early Detection

Who From Oncology is Featured in TIME100 Health 2025?

FDA Announces Aggressive Timeline to Scale 1st AI-Assisted Scientific Review Pilot